baber/WOPTO huggingface dataset:
Patent SG-135175-A1 (SG)
Title: Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
Inventor: BRAHMBHATT HIMANSHU
IPC: A61K47/48
Filed: 2005-01-27
Abstract: A composition comprising intact minicells that contain a drug molecule is useful for targeted drug delivery. One targeted drug delivery method employs bispecific ligands, comprising a first arm that carries specificity for a bacterially derived minicell surface structure and a second arm that carries specificity for a mammalian cell surface receptor, to target drug-loaded minicells to specific mammalian cells and to cause endocytosis of the minicells by the mammalian cells. Another drug delivery method exploits the natural ability of phagocytic mammalian cells to engulf minicells without the use of bispecific ligands.
Patent WO-2009157873-A1 (WO)
Title: Valve hémostatique
Inventor: WONG EN HOU PHILIP
IPC: A61M39/00
Filed: 2008-06-27
Abstract: Valve hémostatique comportant, dans un de ses modes de réalisation, un boîtier de valve recevant un dispositif intra-vasculaire, un premier curseur disposé sur le boîtier de valve et mobile dans une première direction et un deuxième curseur disposé dans le boîtier de valve, mobile dans une deuxième direction et sollicité élastiquement, le premier curseur étant relié fonctionnellement au deuxième curseur via un mécanisme de transmission de telle sorte qu’un mouvement du premier curseur vers un élément élastique de valve dans la première direction fasse s’éloigner le deuxième curseur d’un élément élastique de valve dans la deuxième direction, l’élément élastique de valve étant disposé entre eux et pouvant être comprimé par le deuxième curseur, l’élément élastique de valve recevant le dispositif intra-vasculaire et comprimant ledit dispositif lorsqu’il est lui-même comprimé par le deuxième curseur.
Patent SG-144876-A1 (SG)
Title: A method of processing a workpiece in a plasma reactor with variable height ground return path to control plasma ion density uniformity
Inventor: COLLINS KENNETH S
Filed: 2008-01-25
Abstract: METHOD OF PROCESSING A WORKPIECE IN A PLASMA REACTOR WITH VARIABLE HEIGHT GROUND RETURN PATH TO CONTROL PLASMA ION DENSITY UNIFORMITY A method for processing a workpiece in a plasma reactor chamber includes coupling RF power at a first VHF frequency fl to a plasma via one of the electrodes of the chamber, and providing a center ground return path for RF current passing directly between the ceiling electrode and the workpiece support electrode for the frequency fl. The method further includes providing a variable height edge ground annular element and providing a ground return path through the edge ground annular element for the frequency fl. The method controls the uniformity of plasma ion density distribution by controlling the distance between the variable height edge ground annular element and one of: (a) height of ceiling electrode or (b) height of workpiece support electrode. FIG. 1A
Patent WO-2011010964-A1 (WO)
Title: Differentiation of isobaric amino acids and other species
Inventor: HEATH JAMES R
IPC: C07K1/04
Filed: 2009-07-22
Abstract: Techniques for differentiating isobaric species are described. An isobaric species may be substituted with a tagging species identified using mass spectrometry. The isobaric species may be a subunit of a first polymer having a defined sequence, e.g., the isobaric species may be an amino acid in a protein or a peptide sequence. A tagging species may be substituted for the isobaric species in a second polymer having an otherwise identical sequence as the first polymer. The second polymer may have the same number of sequences as the first polymer, and substantially the same sequence of subunits, with a few exceptions such as the tagging species for the isobaric species. The first polymer and the second polymer may be prepared in the same reaction vessel. A polymer/protein of defined subunit sequence containing an isobaric species or a tagging species may be analyzed by mass spectrometry to determine the sequence.
Patent WO-2011068469-A1 (WO)
Title: Memory card and method for storage and wireless transceiving of data
Inventor: TAN JOON YONG WAYNE
IPC: H04M1/72412
Filed: 2010-03-01
Abstract: A memory card (200) is provided that is configured to be used in a digital camera (100) having an inbuilt processor (104) incapable of independently exporting digital data externally of the digital camera (100) or independently importing digital data from externally of the digital camera (100). The memory card (200) comprises a wireless transceiver module (204) being operably connected to at least one of a central processor (202), and a storage module (206); and is configured to wirelessly receive the digital data transmitted to the digital camera (100) and to wirelessly transmit the digital data from the digital camera (100). The central processor (202) is configured to control at least one of: the reception of the digital data by the digital camera (100), and the transmission of the digital data from the digital camera (100). The storage module (206) is operably connected to the central processor (202) and is configured to store at least one of the digital data captured by the digital camera (100), and the digital data received by the digital camera (100). The memory card (200) is configured to at least one of: wirelessly transmit the digital data to at least one external device through the wireless transceiver module (204), and wirelessly receive the digital data from an external device through the wireless transceiver module (204). The storage of the digital data is able to take place substantially in real time, and the transmission of the digital data is able to take place substantially in real time.
Patent SG-175481-A1 (SG)
Title: System and method for automatic appliance management
Inventor: TAN GUAN HONG
Filed: 2010-05-03
Abstract: An appliance management device can record or store sets of appliance control signalsoutput by remote control units associated with distinct appliances. Such appliancescan differ in appliance type and/or manufacturer. Distinct appliance control signalsets stored within the appliance management device can be identical, similar, ordissimilar with respect to type, format, or communication protocol. In response todetecting a lack of human activity, the appliance management device automaticallyoutputs stored control signal sets to transition a group of appliances to an overallreduced power state. While in an alert mode, in response to detecting an alertcondition indicating the presence of human activity or a threshold condition (e.g., athreshold temperature), the appliance management device automatically sends acorresponding SMS message or an e-mail message. Appliance management devicescan form an appliance management device network in which status information ornotifications can be communicated between appliance management devices.FIG.1
Patent SG-176321-A1 (SG)
Title: A storage area under a portal for reducing portal size in a multi-storey structure
Inventor: WONG LOCK CHANG
Filed: 2010-05-11
Abstract: AbstractA Storage Area Under A Portal For Reducing Portal Size In A Multi-StoreyStructureThe present invention relates to a multi-storied building structure comprising a firstand a second level whereby a ceiling of the first level forms the floor of the secondlevel. The wall of the second level is substantially co-planar with the exterior wall ofthe first level and the ceiling of the first level has a sunken portion, which isproximate, the wall of the first level. A hollow enclosure, which is utilized as astorage area, is defined within the sunken portion of the ceiling. This storage area isaccessible through an opening in the floor of the second level. A portal is definedthrough the wall of the first portal and has a top end proximate the sunken portion ofthe ceiling. The sunken portion of the ceiling reduces the height of this portal withoutsacrificing the aesthetics of the overall ceiling and portal.Figure 1
Patent SG-186504-A1 (SG)
Title: Cross talk reduction for a high speed electrical connector
Inventor: PANG TZE YEONG
Filed: 2011-06-10
Abstract: An electrical connector and a method of fabricating the same are disclosed. The electricalconnector comprises a housing comprising one or more series of electrical pins, wherein each series of electrical pins comprises a plurality of ground pins; and a plurality of signal pins; wherein the signal pins are positioned in between the ground pins, and wherein the plurality of ground pins are integrally connected to each other within the housing. Themethod comprises the steps of providing a housing for holding one or more series of electrical pins; providing a plurality of ground pins and signal pins; and positioning the signal pins in between the ground pins, wherein the plurality of ground pins are integrally connected to each other within the housing.Figure 2
Patent SG-175197-A1 (SG)
Title: Method of controlling power conversion device
Inventor: MASAKAZU MUNESHIMA
Filed: 2010-04-15
Abstract: METHOD OF CONTROLLING POWER CONVERSION DEVICE{Object] To suppress a sudden change of noisc due to a•switching4oss while-HTIproving—a—velta y.[,olution] A correction-term adder 1 compares a maximum value max(V*) with an absolute value of a minimum value min(V*). The correction-term adder 1 selects a signal 1 - max(V*) when the maximum value max(V*) is larger than the absolute value of the minimum value min(V*), on the other hand, selects a signal -1 - min(V*) when the absolute value of the minimum value min(V*) is larger than the maximum value max(V*). Thereby, a signal of correction amount a is calculated. Moreover, the correction-term adder 1 produces a triangular-wave-shaped signal k(max(V*) + min(V*)) by multiplying a gain k by an addition signal max(V*) + min(V*) of the maximum value max(V*) and the minimum value min(V*). This triangular-wave-shaped signal k(max(V*) + min(V*)) is synchronized with the correction amount a . The correction-term adder 1 produces acorrection amount [3 by selecting smaller one in absolute value between the triangular-wave-shaped signal k(max(V*) + min(V*)) and the correction amount a, and adds the correction amount [3 to the voltage command values V*u, V*v, V*w.[Representative drawing] FIG. 2
Patent SG-175844-A1 (SG)
Title: Access control to secured application features using client trust levels
Inventor: KOPPOLU LOKESH SRINIVAS
IPC: G06F21/31
Filed: 2010-06-10
Abstract: Architecture that facilitates the conveyance of a trust level when the caller makes a call, the trust level in dependence on the state of the caller system. The callee (call recipient) receives notification of the trust level and can use this information in the communication such as to request verification from the caller and/or initiate other modes of communication. A caller can authenticate the caller identity in different ways to a communication server. Based on that, the server can assign an appropriate server-verified trust level to the caller. Further, an unsecured phone controller can indicate a lower client- side defined trust level. The server verified and client-side trust levels are then sent to the callee, where the callee determines whether to allow caller access to one or more secured features based on the feature values and the trust level imposed by the callee to access those features.
Patent SG-178334-A1 (SG)
Title: Enhanced high water recovery membrane process
Inventor: AL-SAMADI RIAD
Filed: 2010-08-11
Abstract: Disclosed is an economical process for the purification of water containing soluble and sparingly soluble inorganic compounds using single-stage or two-stage membrane processes that integrate membrane water purification with chemical precipitation softening and residual hardness and silica removal from the membrane concentrates using ion exchange resins and silica sequestering media, respectively. The purified water recovery in the present invention will not be adversely affected by design and/or operational deficiencies in the chemical precipitation softening system that may result in higher residual hardness and silica in the supernatant from the clarifier
Patent SG-178415-A1 (SG)
Title: Method and device for manufacturing titanium objects
Inventor: GULDBERG SIGRID
Filed: 2010-08-11
Abstract: This invention relates to a method and reactor of manufacturing an object by solid freeform fabrication, especially an object made of titanium or titanium alloys. The reactor of production of an object of a weldable material by solid freeform fabrication comprises a reactor chamber which is closed to the ambient atmosphere, wherein the reactor is given a design such that all adjacent wall elements forming the reactor chamber are joined with an obtuse angle (larger than 90°), the actuator located below the reactor chamber is given a design such that the actuator protrudes into the reactor chamber through an opening at the bottom of the reactor chamber holding the support substrate inside the reactor chamber, the opening is sealed by at least one elastic gas impermeable membrane which is gas tight attached to the reactor wall at the opening and to the actuator, the actuator located outside the reactor chamber is given a design such that the actuator protrudes into the reactor chamber through an opening at the side of the reactor chamber holding the high energy plasma transferred arc welding torch with wire feeder of the weldable material inside the reactor chamber, the opening is sealed by the at least one elastic gas impermeable membrane which is gas tight attached to the reactor wall at the opening and to the actuator, and the reactor is equipped with at least one closable gas inlet located at the lowest level of the reactor chamber and at least one closable gas outlet located at the highest level of the reactor chamber.
Patent SG-181107-A1 (SG)
Title: Imp-3 oligopeptides and vaccines including the same
Inventor: NISHIMURA YASUHARU
IPC: A61K39/00
Filed: 2010-11-30
Abstract: Oligopeptides having cytotoxic T cell inducibility and suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines are described herein. Notable examples include oligopeptides having the amino acid sequence of SEQ ID NO: 1, 3, 5 or 6, wherein 1, 2, or several amino acids are optionally substituted, deleted, inserted or added so long as they retain the cytotoxic T cell inducibility of the original oligopeptides. Pharmaceutical formulations or "drugs" related to such oligopeptides suitable for treating or preventing cancers or tumors, as well as the post-operative recurrence thereof, are also described.
Patent SG-181566-A1 (SG)
Title: 4-methylpyrazole formulations
Inventor: DALEY THOMAS E
Filed: 2010-12-06
Abstract: Provided herein are 4-methylpyrazole (4-MP) formulations, stable under storage conditions of up to about 55°C.
Patent SG-181941-A1 (SG)
Title: An elongate heater for an electrically heated aerosol-generating system
Inventor: GREIM OLIVIER
IPC: A24F40/20
Filed: 2010-12-22
Abstract: An electrically heated aerosol-generating system for receiving an aerosol-forming substrate is disclosed. The system comprises a heating element (121) comprising a first electrically conductive element (105) electrically insulated from a second electrically conductive element (109) by an electrically insulating portion (103). The first and second elements are elongate and are electrically connected to each other by an electrically resistive portion (117, 119). At least one electrically conductive element and the electrically resistive portion are arranged such that they are at least partially in contact with the aerosol-forming substrate.
Patent SG-183532-A1 (SG)
Title: Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers
Inventor: MOYO VICTOR
Filed: 2011-03-11
Abstract: Provided are methods of suppressing growth of triple negative breast tumors and basal-like breast tumors by contacting tumor cells with an ErbB3 inhibitor, e.g., an anti- ErbB3 antibody. Also provided are methods for treating triple negative breast cancer or basal-like breast cancer in a patient by administering to the patient an ErbB3 inhibitor, e.g., an anti-ErbB3 antibody. The treatment methods can further comprise selecting a patient having a triple negative breast cancer or basal-like breast cancer and then administering an ErbB3 inhibitor to the patient. The treatment methods also can further comprise administering at least one additional anti-cancer agent to the patient in combination with the ErbB3 inhibitor.
Patent SG-184781-A1 (SG)
Title: Demountable extension socket holder
Inventor: LIM KIAN SENG
Filed: 2010-07-01
Abstract: Title of Invention : Demountable Extension Socket Holder Abstract The Demountable Extension Socket Holder (100) as shown in Figure 1 is a device designed to provide a means to secure any Extension Socket Unit (200) in its bigger "C" channel compartment (120) as shown in Figure 2 firmly onto the edge of side panel or legs any furniture (300) at its smaller "C" channel compartment (130) as shown in Figure 3. The Extension Socket Unit (200) is being held firmly in place by means of two socket head adjustment screws (285) provided at the base of the bigger "C" channel compartment (120). To prevent the adjustment screws (285) from puncturing the Extension Socket Unit (200), the free ends of the adjustment screws (285) are being fitted with capping nuts (288) as shown in Figure 2. The entire assembled units is being clamped firmly into position at the edge or side panel or leg of the furniture (300) at the works station by means of two socket head adjustment screws (385). To prevent the adjustment screws (385) from scratching or damaging the contact surfaces of the furniture, the free ends of the adjustment screws (385) are being fitted with capping nuts (388) as shown in Figure 3.Since the Demountable Extension Socket Holder (100) will be mounted edge or side panel or leg of the furniture (300), it will continue to remain easily and readily accessible after it has been fixed in position. Replacement of the original Extension Socket Unit (200) with a new and different type of Extension Socket unit (200) is very simple as it only involves the loosening of the two adjustment screws (285) securing the Extension Socket Unit (200), dislodging the old Extension Socket Unit (200) from the Demountable Extension Socket Holder (100) and putting in the new and different type of Extension Socket Unit (200) in place and re-tightening the adjustment screws (285). The entire assembly can also be dismantled easily and effortlessly, without the need for any hand tools, simply by literally loosening the adjustment screws (385) with the fingers and re-fixing the entire assembly at any other location desired. As the free ends of the adjustment screws (385) are also fitted with capping nuts (388) there will be no damage caused to the contact surface of the edge or side panel or leg of the furniture (300).[Figure 3]
Patent SG-185522-A1 (SG)
Title: Process for the production of ferrous sulphate monohydrate
Inventor: GATES KIM WILLIAM
Filed: 2011-05-16
Abstract: The invention provides a process for the production of ferrous sulphate monohydrate which comprises: (a) reacting a source of iron with an aqueous solution of sulphuric acid in at least a first reaction vessel, to obtain a process liquor comprising ferrous sulphate and acid solution; and then(b) combining the process liquor with concentrated sulphuric acid in a mixing vessel, causing the solution to self crystallize, thus forming a slurry comprising crystalline ferrous sulfate monohydrate. The slurry can, if desired, then be converted to ferric sulphate.
Patent SG-193105-A1 (SG)
Title: Methods and apparatus for automated noise removal from seismic data
Inventor: JOHN BRITTAN
Filed: 2013-02-18
Abstract: METHODS AND APPARATUS FOR AUTOMATED NOISE REMOVAL FROM SEISMIC DATADisclosed are methods and apparatus for noise removal from seismic data. In one embodiment, a seismic data set comprising a plurality of traces is received, and noise metrics for the seismic data set are computed using a set of time and depth windows. The seismic data set is scanned to determine a first set of groups. Each group in the first set comprises at least a first minimum number of neighboring traces for which at least one of the noise metrics is outside a predefined specification. Noise attenuation is applied to the traces in the first set of groups. Other embodiments, aspects, and features are also disclosed.FIG. 1
Patent SG-195447-A1 (SG)
Title: Operation control system and operation control method for passenger conveyor
Inventor: YOSHIHARU IGARASHI
Filed: 2013-04-11
Abstract: HE-1221-SG[Problem] To detect the existence of a portion from which a step has been removed immediately after a start-up instruction is given to a passenger conveyor so that safety of passengers and workers can be secured before the passenger conveyor is operated at a rated velocity[Solution] An operation control system for an escalator (passenger conveyor) E which includes steps I linked to one another endlessly and travels between upper and lower boarding areas la and lb diagnoses existence of an opening portion caused by a missing one of the steps 1 of the escalator E and controls the travelling of the escalator E based on a result of the diagnosis. The system includes a starting torque calculating portion 8 which calculates driving torque with which the escalator E starts up, and an opening existence diagnosing portion which diagnoses the existence of the opening portion caused by the step, based on a value of the driving torque with which the escalator E starts up and conditions of an operation direction of the escalator E. When the existence of the opening portion is diagnosed, an information unit provides information about the current position of the opening portion. [Selected Drawing] Fig. 2
Patent SG-190248-A1 (SG)
Title: Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins
Inventor: KEER HAROLD
Filed: 2011-11-14
Abstract: The present invention provides methods of treating a patient having a cancer comprising administering to the patient a soluble Fibroblast Growth Factor Receptor 1 (FGFR1) fusion protein such as an extracellular domain of an FGFR1 polypeptide linked to an Fc polypeptide or another fusion partner. The fusion protein may be administered at a dose of at least about 2 mg/kg body weight. In some embodiments, the patient has a fibroblast growth factor-2 (FGF-2) plasma concentration of at least 6 pg/ml. In some embodiments, the cancer is characterized by a Fibroblast Growth Factor Receptor 2 (FGFR2) having a ligand-dependent activating mutation.
Patent SG-192027-A1 (SG)
Title: Nanofiber containing composite structures
Inventor: KAS ONUR Y
Filed: 2012-03-30
Abstract: A composite liquid filtration platform including a composite filtration medium featuring an electrospun polymeric nanofiber layer collected on a porous membrane. When in use, the porous membrane acts as a prefilter used upstream from the polymeric nanofiber layer to remove particles from a liquid stream flowing through the composite filtration structure. The nanofiber layer, positioned downstream from the porous membrane, is used as the retentive layer for critical filtration to provide biosafety assurance, and is responsible for capturing microorganisms like bacteria, mycoplasma or viruses. The composite liquid filtration platform provided herein exhibits permeability advantages over conventional porous membranes or nanofiber mats spun on coarse non-wovens.
Patent SG-196770-A1 (SG)
Title: Method for treating macular degeneration
Inventor: HAHN CHANG S
Filed: 2009-12-18
Abstract: METHOD FOR TREATING MACULAR DEGENERATIONProvided herein are novel and useful methods for preventing, treating, or ameliorating amacular degeneration such as dry macular degeneration, wet macular degeneration and age relatedmacular degeneration in a patient.[No Fig.] METHOD FOR TREATING MACULAR DEGENERATION Provided hereinare novel and useful methods for preventing, treating, or ameliorating amacular degeneration such as dry macular degeneration, wet maculardegeneration and age related macular degeneration in a patient. [No Fig.]